Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes
Bettina Brandt1, Tom Büchse, Ehab Fathi Abou-Eladab
1Medical Faculty, Institute of Medical Biochemistry and Molecular Biology, University of Rostock, Schillingallee 70, 18057 Rostock, Germany.
Abstract:
Galectin-1 (gal-1), a member of the family of beta-galactoside binding proteins, participates in several biological processes such as immunomodulation, cell adhesion, regulation of cell growth and apoptosis. The aim of this study was to investigate whether gal-1 interferes with the Fas (Apo-1/CD95)-associated apoptosis cascade in the T-cell lines Jurkat and MOLT-4. Gal-1 and an Apo-1 monoclonal antibody (mAb) induced DNA-fragmentation in Jurkat T-cells whereas MOLT-4 cells were resistant. Gal-1 stimulated DNA-fragmentation could be efficiently inhibited by caspase-8 inhibitor II (Z-IETD-FMK) and a neutralizing Fas mAb. Fas could be identified as a target for gal-1 recognition as demonstrated by immunofluorescence staining, binding of the receptor glycoprotein to immobilized gal-1 and analyses by immunoblotting as well as by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Gal-1 stimulates the activation and proteolytic processing of procaspase-8 and downstream procaspase-3 in Jurkat-T cells. Inhibition of gal-1 induced procaspase-8 activation by a neutralizing Fas mAb strongly suggests that gal-1 recognition of Fas is associated with caspase-8 activation. Our data provide the first experimental evidence for targeting of gal-1 to glycotopes on Fas and the subsequent activation of the apoptotic death-receptor pathway.
Insights
Galectin-1 (gal-1) triggers apoptosis in Jurkat T-cells by binding to Fas receptors and activating caspases. This interaction highlights gal-1
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Galectin-1 (gal-1) is a beta-galactoside binding protein involved in immune regulation, cell growth, and apoptosis.
- The Fas (Apo-1/CD95) receptor pathway is crucial for initiating programmed cell death (apoptosis).
Purpose of the Study:
- To investigate if galectin-1 influences the Fas-associated apoptosis cascade in T-cell lines.
- To determine the mechanism by which gal-1 interacts with the Fas pathway.
Main Methods:
- Utilized Jurkat and MOLT-4 T-cell lines.
- Induced apoptosis using gal-1 and anti-Fas antibodies.
- Assessed DNA fragmentation and caspase activation.
- Employed immunofluorescence, protein binding assays, immunoblotting, and LC-MS/MS to identify gal-1 targets.
Main Results:
- Galectin-1 induced DNA fragmentation in Jurkat cells, but not in MOLT-4 cells.
- This effect was blocked by caspase-8 inhibitors and neutralizing anti-Fas antibodies.
- Fas was identified as a direct binding target for gal-1.
- Gal-1 promoted the activation and processing of procaspase-8 and procaspase-3.
Conclusions:
- Galectin-1 directly targets Fas receptors on T-cells, initiating the apoptotic pathway.
- Gal-1 binding to Fas leads to caspase-8 activation and subsequent downstream apoptosis.
- These findings reveal a novel mechanism of gal-1-mediated apoptosis through the Fas death-receptor pathway.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...


